May 2001 Cover
|
 |
Researchers report that structured treatment interruptions to the drug therapy of HIV patients could significantly increase the risk of drug-resistant HIV-1.
The structured interruptions have been suggested as a way of building up an HIV-infected individual's natural immune system and increasing the effectiveness of antiretroviral treatments. Researchers suggest that in lieu
of these structured interruptions, alternative immune stimulants, such as interleukin-2 or a therapeutic vaccine, be used during continued antiretroviral treatment.
Editor's Note: from Reuters Health Info Services
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
